Free Trial

Rentokil Initial (RKLIF) Financials

Rentokil Initial logo
$6.37 0.00 (0.00%)
As of 05/4/2026
Annual Income Statements for Rentokil Initial

Annual Income Statements for Rentokil Initial

This table shows Rentokil Initial's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
254 355 280 622 363 588
Consolidated Net Income / (Loss)
254 355 280 474 392 470
Net Income / (Loss) Continuing Operations
254 355 280 574 308 398
Total Pre-Tax Income
314 439 357 703 424 498
Total Operating Income
402 468 383 567 446 380
Total Gross Profit
402 468 412 616 517 454
Total Revenue
3,828 3,992 4,485 6,445 6,676 6,954
Operating Revenue
3,828 3,992 4,485 6,445 6,676 6,954
Total Cost of Revenue
3,427 3,524 4,074 5,829 6,159 6,500
Operating Cost of Revenue
3,427 3,524 4,074 5,829 6,159 6,500
Total Operating Expenses
0.00 0.00 29 49 71 74
Impairment Charge
0.00 0.00 29 49 71 74
Total Other Income / (Expense), net
-87 -30 -25 136 -22 118
Interest & Investment Income
8.19 5.40 59 136 -22 129
Other Income / (Expense), net
11 11 11 0.00 0.00 -11
Income Tax Expense
60 84 77 129 116 100
Other Adjustments to Consolidated Net Income / (Loss)
- - - 48 55 190
Weighted Average Basic Shares Outstanding
- - 2.52B 2.52B 2.52B 2.53B
Weighted Average Diluted Shares Outstanding
- - 2.52B 2.52B 2.52B 2.53B
Weighted Average Basic & Diluted Shares Outstanding
- - 2.52B 2.52B 2.52B 2.53B

Quarterly Income Statements for Rentokil Initial

No quarterly income statements for Rentokil Initial are available.


Annual Cash Flow Statements for Rentokil Initial

This table details how cash moves in and out of Rentokil Initial's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
382 -398 -827 56 182 1,025
Net Cash From Operating Activities
478 437 402 354 401 -181
Net Cash From Continuing Operating Activities
478 437 402 354 401 -181
Net Income / (Loss) Continuing Operations
0.00 0.00 0.00 0.00 0.00 0.00
Depreciation Expense
- 278 307 341 361 327
Non-Cash Adjustments To Reconcile Net Income
478 123 95 13 40 -650
Changes in Operating Assets and Liabilities, net
- 36 - - - 142
Net Cash From Investing Activities
-434 -616 -1,229 -298 -219 -309
Net Cash From Continuing Investing Activities
-434 -616 -1,229 -298 -219 -309
Purchase of Property, Plant & Equipment
-178 - - - - -208
Acquisitions
-265 -625 -1,229 -298 -219 -121
Sale of Property, Plant & Equipment
8.19 9.45 - - - 20
Net Cash From Financing Activities
462 -225 0.00 0.00 0.00 532
Net Cash From Continuing Financing Activities
462 -225 0.00 0.00 0.00 532
Repayment of Debt
-1,846 -225 - - - -700
Issuance of Debt
2,308 - - - - 1,232
Other Net Changes in Cash
- - - - - 391
Cash Interest Paid
67 57 - - - 255
Cash Interest Received
11 6.75 16 31 46 31
Cash Income Taxes Paid
87 - - - - 104

Quarterly Cash Flow Statements for Rentokil Initial

No quarterly cash flow statements for Rentokil Initial are available.


Annual Balance Sheets for Rentokil Initial

This table presents Rentokil Initial's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
5,736 14,163 13,888 12,913 14,097
Total Current Assets
1,814 3,909 3,435 2,611 3,859
Cash & Equivalents
902 2,621 1,989 1,158 2,319
Short-Term Investments
5.40 1.21 19 1.00 63
Accounts Receivable
711 1,002 1,121 1,137 1,151
Inventories, net
184 242 264 287 308
Current Deferred & Refundable Income Taxes
12 43 42 28 18
Plant, Property, & Equipment, net
537 598 636 628 445
Plant, Property & Equipment, gross
537 598 636 628 445
Total Noncurrent Assets
3,384 9,656 9,817 9,674 9,793
Long-Term Investments
41 104 83 72 66
Intangible Assets
2,921 8,820 8,970 8,899 8,917
Noncurrent Deferred & Refundable Income Taxes
57 52 55 43 55
Other Noncurrent Operating Assets
366 680 709 660 755
Total Liabilities & Shareholders' Equity
5,837 14,422 14,173 13,211 14,434
Total Liabilities
4,131 9,473 8,965 7,918 8,940
Total Current Liabilities
1,877 3,429 3,284 3,224 3,315
Short-Term Debt
620 1,624 1,444 1,460 1,411
Accounts Payable
1,031 1,408 1,457 1,400 1,392
Current Deferred & Payable Income Tax Liabilities
82 72 61 53 61
Other Current Liabilities
143 324 322 311 451
Total Noncurrent Liabilities
2,255 6,045 5,681 4,694 5,625
Long-Term Debt
1,696 4,316 4,016 3,127 4,156
Capital Lease Obligations
188 393 405 394 392
Noncurrent Deferred & Payable Income Tax Liabilities
146 620 659 638 589
Noncurrent Employee Benefit Liabilities
36 36 36 32 27
Other Noncurrent Operating Liabilities
189 680 565 503 461
Total Equity & Noncontrolling Interests
1,706 4,949 5,208 5,293 5,494
Total Preferred & Common Equity
1,708 4,950 5,210 5,295 5,496
Preferred Stock
9.45 11 19 20 21
Total Common Equity
1,698 4,939 5,191 5,275 5,475
Common Stock
26 30 41 41 41
Retained Earnings
4,274 3,988 6,053 6,166 6,380
Other Equity Adjustments
-2,601 921 -903 -932 -946
Noncontrolling Interest
-1.35 -1.21 -2.00 -2.00 -2.00

Quarterly Balance Sheets for Rentokil Initial

No quarterly balance sheets for Rentokil Initial are available.


Annual Metrics And Ratios for Rentokil Initial

This table displays calculated financial ratios and metrics derived from Rentokil Initial's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - 2,526,039,885.00
DEI Adjusted Shares Outstanding
- - - - - 2,526,039,885.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - 0.23
Growth Metrics
- - - - - -
Profitability Metrics
- - - - - -
Net Operating Profit after Tax (NOPAT)
325 379 300 616 521 304
Return On Investment Capital (ROIC_SIMPLE)
- - 2.66% 5.56% 5.07% 2.65%
Earnings before Interest and Taxes (EBIT)
412 479 394 808 696 369
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
412 757 700 1,157 1,049 696
Valuation Ratios
- - - - - -
Leverage & Solvency
- - - - - -
Liquidity Ratios
- - - - - -
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -2,781 -4,836 213 476 381
Efficiency Ratios
- - - - - -
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 3,160 8,297 8,700 8,745 8,668
Increase / (Decrease) in Invested Capital
0.00 3,160 5,137 403 45 -77
Book Value per Share
$0.00 $0.00 $1.96 $2.06 $2.09 $2.17
Tangible Book Value per Share
$0.00 $0.00 ($1.54) ($1.50) ($1.44) ($1.36)
Total Capital
0.00 4,209 11,282 11,077 10,276 11,453
Total Debt
0.00 2,503 6,333 5,868 4,982 5,959
Total Long-Term Debt
0.00 1,883 4,709 4,423 3,522 4,548
Net Debt
0.00 1,555 3,607 3,776 3,749 3,511
Capital Expenditures (CapEx)
169 -9.45 0.00 0.00 0.00 188
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -350 -517 -414 -312 -427
Debt-free Net Working Capital (DFNWC)
0.00 558 2,105 1,595 849 1,955
Net Working Capital (NWC)
0.00 -62 481 150 -611 544
Net Nonoperating Expense (NNE)
71 24 20 130 137 -166
Net Nonoperating Obligations (NNO)
0.00 1,454 3,348 3,490 3,451 3,174
Total Depreciation and Amortization (D&A)
0.00 278 307 349 353 327
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.15 $0.15 $0.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 2.52B 2.52B 2.53B
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.15 $0.15 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 2.52B 2.52B 2.53B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 2.52B 2.52B 2.53B
Normalized Net Operating Profit after Tax (NOPAT)
325 379 323 654 574 363
Debt Service Ratios
- - - - - -
Payout Ratios
- - - - - -

Quarterly Metrics And Ratios for Rentokil Initial

No quarterly metrics and ratios for Rentokil Initial are available.



Financials Breakdown Chart

Frequently Asked Questions About Rentokil Initial's Financials

When does Rentokil Initial's financial year end?

According to the most recent income statement we have on file, Rentokil Initial's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Rentokil Initial's net income changed over the last 5 years?

Rentokil Initial's net income appears to be on an upward trend, with a most recent value of $470 million in 2025, rising from $254.02 million in 2020. The previous period was $392 million in 2024.

What is Rentokil Initial's operating income?
Rentokil Initial's total operating income in 2025 was $380 million, based on the following breakdown:
  • Total Gross Profit: $454 million
  • Total Operating Expenses: $74 million
How has Rentokil Initial's revenue changed over the last 5 years?

Over the last 5 years, Rentokil Initial's total revenue changed from $3.83 billion in 2020 to $6.95 billion in 2025, a change of 81.7%.

How much debt does Rentokil Initial have?

Rentokil Initial's total liabilities were at $8.94 billion at the end of 2025, a 12.9% increase from 2024, and a 116.4% increase since 2021.

How much cash does Rentokil Initial have?

In the past 4 years, Rentokil Initial's cash and equivalents has ranged from $901.80 million in 2021 to $2.62 billion in 2022, and is currently $2.32 billion as of their latest financial filing in 2025.

How has Rentokil Initial's book value per share changed over the last 5 years?

Over the last 5 years, Rentokil Initial's book value per share changed from 0.00 in 2020 to 2.17 in 2025, a change of 216.9%.



Financial statements for OTCMKTS:RKLIF last updated on 3/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners